Appendix 2—table 45. Antidepressant User Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Antidepressant Users by BP: Unmatched | Region=NY Antidepressant Users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 135,516 | 100.0% | 122,566 | 90.4% | 12,950 | 9.6% | 25,718 | 100.0% | 12,859 | 50.0% | 12,859 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 4,363 | 3.2% | 4,357 | 3.6% | 6 | 0.0% | <0.001 | 12 | 0.0% | 6 | 0.0% | 6 | 0.0% | 1.00 |
| 21-40 | 22,834 | 16.8% | 22,770 | 18.6% | 64 | 0.5% | 126 | 0.5% | 62 | 0.5% | 64 | 0.5% | ||
| 41-50 | 18,482 | 13.6% | 18,263 | 14.9% | 219 | 1.7% | 440 | 1.7% | 221 | 1.7% | 219 | 1.7% | ||
| 51-60 | 29,485 | 21.8% | 27,702 | 22.6% | 1,783 | 13.8% | 3,570 | 13.9% | 1,788 | 13.9% | 1,782 | 13.9% | ||
| 61-70 | 27,540 | 20.3% | 23,385 | 19.1% | 4,155 | 32.1% | 8,292 | 32.2% | 4,146 | 32.2% | 4,146 | 32.2% | ||
| 71-80 | 21,038 | 15.5% | 16,548 | 13.5% | 4,490 | 34.7% | 8,863 | 34.5% | 4,430 | 34.5% | 4,433 | 34.5% | ||
| ≥81 | 11,774 | 8.7% | 9,541 | 7.8% | 2,233 | 17.2% | 4,415 | 17.2% | 2,206 | 17.2% | 2,209 | 17.2% | ||
| Gender | ||||||||||||||
| Female | 96,462 | 71.2% | 84,469 | 68.9% | 11,993 | 92.6% | <0.001 | 23,810 | 92.6% | 11,906 | 92.6% | 11,904 | 92.6% | 0.96 |
| Male | 39,054 | 28.8% | 38,097 | 31.1% | 957 | 7.4% | 1,908 | 7.4% | 953 | 7.4% | 955 | 7.4% | ||
| Insurance | ||||||||||||||
| Commercial | 51,829 | 38.2% | 49,332 | 40.2% | 2,497 | 19.3% | <0.001 | 4,991 | 19.4% | 2,495 | 19.4% | 2,496 | 19.4% | 1.00 |
| Dual | 1,600 | 1.2% | 1,221 | 1.0% | 379 | 2.9% | 710 | 2.8% | 356 | 2.8% | 354 | 2.8% | ||
| Medicaid | 38,567 | 28.5% | 36,366 | 29.7% | 2,201 | 17.0% | 4,269 | 16.6% | 2,131 | 16.6% | 2,138 | 16.6% | ||
| Medicare | 43,520 | 32.1% | 35,647 | 29.1% | 7,873 | 60.8% | 15,748 | 61.2% | 7,877 | 61.3% | 7,871 | 61.2% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 53,400 | 39.4% | 48,911 | 39.9% | 4,489 | 34.7% | <0.001 | 8,901 | 34.6% | 4,449 | 34.6% | 4,452 | 34.6% | 0.97 |
| Yes | 82,116 | 60.6% | 73,655 | 60.1% | 8,461 | 65.3% | 16,817 | 65.4% | 8,410 | 65.4% | 8,407 | 65.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.96 | 1.68 | 0.95 | 1.66 | 1.13 | 1.78 | <0.001 | 1.12 | 1.76 | 1.12 | 1.75 | 1.12 | 1.77 | 0.86 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.